Webinar Recording Request
Increasing Peptide Half-Life Through Conjugation Or Recombinant Fusion To XTEN Protein Polymers.
Hosted by Volker Schellenberger, President and CEO, Amunix ; Tuesday 1st December | 2.30pm GMT
Peptides are constantly in demand as active pharmaceutical ingredients thanks to their unique abilities. In addition to this, the peptides market is growing rapidly as a result of the recent advancements in peptides research. Our free webinar offers attendees the opportunity to hear about XTEN, a protein-based polymer for extending the half-life of peptides
This webinar recording offers you the chance to hear from Volker Schellenberger, President and CEO, Amunix about “Increasing Peptide Half-Life Through Conjugation Or Recombinant Fusion To XTEN Protein Polymers”.
Benefits of the webinar recording:
• Learn about a clinically validated alternative to PEGylation that addresses PEG-related safety concerns
• Gain more information on how one can increase half-life while avoiding the typical PEG-related potency reduction
Who Should Download the webinar recording?
Our free webinar is for peptides experts based in the EU and US interested in learning more about the therapeutic potential of peptides as well as advancements in peptides technologies.
Download the recording here: